Cladribine With Concurrent Rituximab for Hairy Cell Leukemia Variant
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Blood Advances
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variant
Blood Adv 2021 Dec 14;5(23)4807-4816, D Chihara, E Arons, M Stetler-Stevenson, C Yuan, HW Wang, H Zhou, M Raffeld, L Xi, SM Steinberg, J Feurtado, L James-Echenique, CH Tai, KP Patel, RC Braylan, KR Calvo, I Maric, A Dulau-Florea, RJ KreitmanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.